Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -4.68
- Piotroski Score 4.00
- Grade Outperform
- Symbol (APLT)
- Company Applied Therapeutics, Inc.
- Price $9.01
- Changes Percentage (0.95%)
- Change $0.09
- Day Low $8.71
- Day High $9.29
- Year High $10.62
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/05/2025
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.91
- Trailing P/E Ratio -2.45
- Forward P/E Ratio -2.45
- P/E Growth -2.45
- Net Income $-119,763,000
Income Statement
Quarterly
Annual
Latest News of APLT
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Why Is Applied Therapeutics, Inc. (APLT) the Best Biotech Penny Stock to Buy Now?
Discover the top biotech penny stocks to buy now. Applied Therapeutics (NASDAQ: APLT) emerges as a promising choice, focusing on rare CNS diseases and diabetic complications....
By Yahoo! Finance | 4 months ago -
Here's Why We're Not Too Worried About Applied Therapeutics' (NASDAQ:APLT) Cash Burn Situation
Despite being unprofitable, Applied Therapeutics' stock has surged 244% in the last year, raising concerns about its cash burn. With a cash runway of 2.2 years and increasing cash burn, investors must...
By Yahoo! Finance | 4 months ago
